Teva suit against generic Momenta over Copaxone proceeds in SDNY
Teva, the world's largest generic drug company, won a court battle in SDNY in its role as a proprietary drug company making Copaxone, against Novartis AG's Sandoz unit, Momenta Pharmaceuticals Inc., Mylan Inc., and Natco Pharma Ltd. Claim constructions favorable to Teva were accepted. On Aug. 29, U.S. District Judge Barbara Jones dismissed Mylan’s claim that Teva’s patent for the drug was invalid. Trial will begin 7 Sept 11. Copaxone is the top MS drug in the world by revenue.
The Sandoz case is Teva Phamaceutical Industries Ltd. v. Sandoz Inc., 08-7611, U.S. District Court, Southern District of New York (Manhattan). The Mylan case is Teva Pharmaceuticals Industries Ltd. v. Mylan Inc., 09-8824, U.S. District Court, Southern District of New York (Manhattan).
The Sandoz case is Teva Phamaceutical Industries Ltd. v. Sandoz Inc., 08-7611, U.S. District Court, Southern District of New York (Manhattan). The Mylan case is Teva Pharmaceuticals Industries Ltd. v. Mylan Inc., 09-8824, U.S. District Court, Southern District of New York (Manhattan).
posted by Lawrence B. Ebert at 5:18 AM
2 Comments:
Too bad the SDNY doesn't post its non-BR cases on-line via PACER.
Is there somewhere that one can see the relevant orders in the case?
Post a Comment
<< Home